The benchmark Nifty 50 index failed to surpass previous session’s high of 23,869 on Tuesday Immediate resistance for the ...

Among the S&P 500, 34% of stocks showed declines for 2024 through the year's second-to-last trading session. There were 96 stocks down at least 10%, and 57 that were down at least 20%. Here are the 20 ...

Stocks are skipping the ‘Santa Claus rally’ again this year. That doesn’t bode well for January. The Fed has two bad options ...

Here are the 20 stocks in the S&P 500 showing the largest gains for 2024: Palantir Technologies (PLTR) was way out front with a 2024 gain of 340.5%. The company develops security and data-analysis ...

The S&P 500 posted back-to-back annual gains of more than 20 percent for the first time since the late 1990s. Analysts expect ...

Exciting news in the biotech industry as positive phase 2 results for sevasemten in BMD drive long-term investment potential ...

"Bottom line, for stocks to enjoy a good year in 2025, policy from the Trump administration will have to deliver more ...

Indexes rose moderately to kick off the final session of 2024, with traders getting ready to close out a year of stellar ...

As the U.S. stock market looks to rebound from a recent end-of-year slump, major indices like the Nasdaq and S&P 500 have still managed to post significant gains for the year. In this environment, ...

Hims & Hers Health shares are currently trading up by 1.11%, with a current price of $25.45 as of Tuesday morning. This brings the total value of Baird's 31,518 shares to $658,464.

It's the final trading day of 2024. The NYSE will close on Jan. 9 to honor late former President Jimmy Carter. Natural gas prices are rising.

Discover the sectors set to dominate in 2025 with insights from ratio analysis and multi-timeframe trends. Here’s how ...